HomeIVRN • OTCMKTS
add
Innoveren Scientific Inc
Previous close
$0.000010
Market cap
10.00 USD
Avg Volume
54.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 421.27K | -30.92% |
Net income | -495.78K | 78.25% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -419.65K | 30.72% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 543.88K | 1,381.04% |
Total assets | 789.32K | 228.12% |
Total liabilities | 11.68M | 39.20% |
Total equity | -10.89M | — |
Shares outstanding | 712.71K | — |
Price to book | -0.00 | — |
Return on assets | -211.18% | — |
Return on capital | 16.98% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Net income | -495.78K | 78.25% |
Cash from operations | -325.98K | -10.64% |
Cash from investing | 869.25K | 185,240.94% |
Cash from financing | -12.00K | -104.21% |
Net change in cash | 531.27K | 5,903.70% |
Free cash flow | 728.30K | -38.94% |
About
Founded
2013
Headquarters
Website
Employees
2
